Clinical trials
Terminated Phase 2/3 trials in Portugal
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2011 | 1 |
| 2013 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 14 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Boehringer Ingelheim | 2 |
| Theravance Biopharma | 2 |
| Aerovate Therapeutics | 1 |
| Biohaven Therapeutics Ltd. | 1 |
| Biotronik, Inc. | 1 |
| Genzyme, a Sanofi Company | 1 |
| Gilead Sciences | 1 |
| Jan Stam, MD, PhD | 1 |
| Novartis Pharmaceuticals | 1 |
| Oslo University Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| COVID-19 | 2 |
| Colitis, Ulcerative | 2 |
| Inflammatory Bowel Diseases | 2 |
| Alzheimer Disease | 1 |
| Communicable Diseases, Emerging | 1 |
| Coronavirus Infections | 1 |
| Drug Resistant Epilepsy | 1 |
| Epilepsy | 1 |
| Epilepsy, Absence | 1 |
| Epilepsy, Generalized | 1 |
Trials
Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.